Phospho-PRKCD (Ser645) Antibody

What is the biological significance of PKCδ Ser645 phosphorylation?

PKCδ (Protein Kinase C Delta) is a calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in multiple cellular processes including cell growth, differentiation, and apoptosis. Phosphorylation at Ser645 is located in the "turn motif" region and represents one of three critical phosphorylation sites required for full PKCδ activation, alongside Thr507 (activation loop) and Ser664 (hydrophobic region) .

Ser645 phosphorylation is a key regulatory event that modulates PKCδ activity and can be dynamically regulated in response to various stimuli. This site has particular importance in:

• Mediating PKCδ's role in immune homeostasis

• Regulating tumor cell survival and resistance to apoptosis

• Contributing to cellular responses during oxidative stress

• Participating in viral infection mechanisms

Research has shown that PKCδ's dysregulation has been implicated in cancer progression, inflammatory responses, and several neurological disorders, making the monitoring of its phosphorylation status at Ser645 valuable for understanding disease mechanisms .

What experimental techniques are compatible with Phospho-PRKCD (Ser645) antibodies?

Phospho-PRKCD (Ser645) antibodies have been validated for multiple experimental techniques, with varying recommended dilutions:

For optimal results, researchers should:

• Validate antibody specificity using appropriate positive and negative controls

• Optimize dilutions for each specific application and cell/tissue type

• Consider using phosphatase inhibitors during sample preparation to preserve phosphorylation status

How should researchers validate the specificity of Phospho-PRKCD (Ser645) antibodies?

Methodological approach to antibody validation:

• Western blot confirmation: Verify that the antibody detects a single band of the expected molecular weight (~78 kDa for PKCδ)

• Phosphorylation-specific controls:

  • Treat cells with phosphatase to eliminate the signal

  • Use stimulus-responsive models with known induction of Ser645 phosphorylation (e.g., LPS treatment or PMA)

  • Compare with total PKCδ antibody to confirm specificity for the phosphorylated form

• Peptide competition assay: Pre-incubate antibody with phosphorylated and non-phosphorylated peptides to demonstrate phospho-specificity

• Cross-reactivity assessment: Test against multiple cell lines or tissues to confirm consistent detection of the target

• Immunogen verification: Confirm the antibody was generated against a phosphopeptide containing the Ser645 site (typically with sequence R-L-S(p)-Y-S)

For example, researchers at Boster Biological Technology validated their antibody (A00822S645) using Western blot against multiple cell lysates and immunohistochemistry with human breast carcinoma tissue to demonstrate phospho-specificity and reproducibility .

What experimental stimuli can be used to induce PKCδ Ser645 phosphorylation for positive controls?

Several stimuli have been demonstrated to induce PKCδ Ser645 phosphorylation:

Methodology for LPS stimulation:

• Culture cells in appropriate media (e.g., RPMI 1640)

• Treat with LPS at concentrations of 0.1, 1, 10, and 100 μg/mL

• Harvest cells at defined time points (2, 4, 6, 8, and 24 hours)

• Prepare lysates with phosphatase inhibitors

• Analyze PKCδ Ser645 phosphorylation by Western blot

Research by Liu et al. demonstrated that both mRNA and protein expression levels of PKCδ increased in a concentration- and time-dependent manner following LPS stimulation, with corresponding increases in phosphorylation at key regulatory sites including Ser645 .

What are the optimal sample preparation methods for detecting PKCδ Ser645 phosphorylation?

Protocol for optimal sample preparation:

• Cell/Tissue Lysis:

  • Harvest cells at 70-80% confluence

  • Wash cells twice with ice-cold PBS

  • Lyse cells in buffer containing:

    • 20 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • 1% Triton X-100

    • 1 mM EDTA

    • 1 mM EGTA

    • Critical: Add fresh phosphatase inhibitors (10 mM NaF, 2 mM Na₃VO₄, 1 mM PMSF, 10 mM β-glycerophosphate)

• Protein Extraction:

  • Incubate lysates on ice for 30 minutes with occasional vortexing

  • Centrifuge at 14,000 × g for 15 minutes at 4°C

  • Collect supernatant containing total protein

• Protein Quantification:

  • Determine protein concentration using BCA or Bradford assay

  • Normalize all samples to equal protein concentration (typically 1-2 mg/mL)

• Sample Preparation for Western Blot:

  • Mix protein samples with Laemmli buffer (4:1)

  • Heat at 95°C for 5 minutes

  • Load 20-40 μg protein per lane

• Special Considerations:

  • For phosphorylation studies, avoid repeated freeze-thaw cycles

  • Process samples immediately after collection when possible

  • For immunohistochemistry, use freshly prepared or properly fixed tissues

When monitoring PKCδ phosphorylation dynamics, timing is critical as phosphorylation status can change rapidly. Research by Wadzinski et al. demonstrated that phosphorylation levels at Ser645 can fluctuate significantly within minutes following stimulation, necessitating careful experimental design and sample collection timing .

How can Phospho-PRKCD (Ser645) antibodies be used to investigate signaling pathways in disease models?

Methodological framework for disease-specific signaling studies:

• Cancer research applications:

  • Compare Ser645 phosphorylation levels between tumor and adjacent normal tissues

  • Correlate phosphorylation status with tumor aggressiveness and treatment resistance

  • Investigate PKCδ's dual role as both tumor suppressor and promoter depending on context

  • Example approach: Use tissue microarrays with matched phospho-PKCδ and total PKCδ antibodies to correlate expression patterns with clinical outcomes

• Autoimmune disease models:

  • Evaluate PKCδ phosphorylation in B-cell populations from SLE patients

  • Study correlation between phosphorylation status and B-cell tolerance breakdown

  • Monitor changes in Ser645 phosphorylation during disease progression and treatment

  • Experimental design: Compare peripheral blood B-cells from healthy controls vs. autoimmune patients using flow cytometry with phospho-specific antibodies

• Viral infection studies:

  • Examine PKCδ phosphorylation during viral infection cycles

  • Investigate virus-specific effects on PKCδ activation

  • Example from research: HSV-1 infection induces PKCδ phosphorylation at Ser645 in a γ134.5-dependent manner as demonstrated by Wilcox et al.

• Neurodegenerative disorders:

  • Assess PKCδ phosphorylation in affected brain regions

  • Correlate with markers of neuronal damage and inflammation

  • Methodology: Multiplex immunofluorescence combining phospho-PKCδ with cell-type specific markers

For quantitative analysis across disease models, researchers can employ:

• Phosphoproteomics to identify novel PKCδ-dependent pathways

• Single-cell analysis to detect heterogeneity in phosphorylation patterns

• Computational modeling to predict functional consequences of altered phosphorylation

A systematic approach should include appropriate disease controls and time-course studies to capture dynamic changes in phosphorylation status.

What methodologies can be employed to study the temporal dynamics of PKCδ Ser645 phosphorylation?

Advanced techniques for temporal phosphorylation studies:

• Live-cell imaging with phospho-specific biosensors:

  • Design FRET-based reporters containing the Ser645 region

  • Monitor real-time phosphorylation changes in response to stimuli

  • Quantify spatial and temporal dynamics simultaneously

  • Technical considerations: Requires genetic engineering of cell lines; signal-to-noise optimization critical

• Microfluidic-based kinetic analyses:

  • Apply stimuli with precise temporal control

  • Collect lysates at defined intervals (seconds to hours)

  • Process multiple conditions simultaneously

  • Example protocol: Use microfluidic chip with integrated cell culture chambers and automated lysate collection

• Phosphorylation mass spectrometry with TMT labeling:

  • Collect samples across multiple timepoints

  • Apply multiplexed TMT labeling to quantify relative phosphorylation

  • Identify not only Ser645 but all PKCδ phosphorylation sites simultaneously

  • Advantages: Comprehensive phosphoproteome coverage; high sensitivity

• Pulsed SILAC for phosphorylation turnover:

  • Pulse cells with heavy-labeled amino acids

  • Track incorporation into newly synthesized PKCδ

  • Determine phosphorylation turnover rates at Ser645

  • Application: Distinguishing between increased phosphorylation vs. decreased dephosphorylation

• Automated Western blot time-course:

  • Utilize automated Western blot systems (e.g., Jess, Wes)

  • Standardize detection across multiple timepoints

  • Generate quantitative kinetic data on phosphorylation

  • Data presentation: Time-course curves with statistical analysis

Example experimental design for stimulation time-course:

• Treat cells with stimulus (e.g., LPS at 10 μg/mL)

• Collect samples at 0, 5, 15, 30, 60, 120, 240, 480 minutes

• Process all samples with identical protocols

• Normalize phospho-signal to total PKCδ levels

• Plot relative phosphorylation vs. time with error bars

Research by Liu et al. demonstrated that LPS treatment increases PKCδ phosphorylation in a time-dependent manner, with significant changes observable between 2-8 hours post-stimulation .

How can researchers investigate the interplay between PKCδ Ser645 phosphorylation and other post-translational modifications?

Integrated analytical approaches:

• Sequential immunoprecipitation strategy:

  • First IP: Pull down with phospho-Ser645 specific antibody

  • Second IP: Analyze additional modifications on the phosphorylated subpopulation

  • Applications: Determine co-occurrence of phosphorylation, ubiquitination, acetylation

  • Protocol considerations: Use gentle elution methods between IPs to preserve modifications

• Multi-dimensional phosphoproteomics:

  • Enrich for PKCδ using specific antibodies

  • Employ TiO₂ or IMAC for phosphopeptide enrichment

  • Analyze by LC-MS/MS with fragmentation optimized for phosphopeptide detection

  • Data analysis: Identify peptides with multiple phosphorylation sites

• Site-directed mutagenesis combined with phospho-specific antibodies:

  • Generate PKCδ mutants (S645A, S645D, Y311F, etc.)

  • Express in cellular models and analyze phosphorylation patterns

  • Assess how mutation at one site affects phosphorylation at others

  • Example: Research by Gong et al. showed that phosphorylation at Tyr313 affects Ser359 phosphorylation status

• Kinase-substrate relationship mapping:

  • Identify kinases responsible for Ser645 phosphorylation

  • Determine if other PKCδ phosphorylation sites share kinases

  • Investigate cross-talk between different signaling cascades

  • Approach: Use selective kinase inhibitors in combination with phospho-specific antibodies

Critical considerations:

• Phosphatase inhibition is essential to preserve phosphorylation status

• Controls for antibody cross-reactivity between phosphorylation sites

• Context-dependency (cell type, stimulus, timing) of modification patterns

Research findings indicate complex relationships between phosphorylation sites. For example:

• Phosphorylation at Tyr311 can enhance Thr505 autophosphorylation

• Ser359 phosphorylation status affects substrate specificity toward serine vs. threonine residues

• The C2 domain interactions with phosphotyrosine residues can indirectly control phosphorylation at other sites

These interconnected modifications create a complex regulatory network that fine-tunes PKCδ function in different cellular contexts.

What strategies can address contradictory findings in PKCδ Ser645 phosphorylation research?

Methodological approaches to resolve research discrepancies:

• Standardization of experimental protocols:

  • Document complete antibody validation procedures

  • Specify exact stimulation conditions (concentration, timing, medium composition)

  • Report cell density, passage number, and authentication methods

  • Recommendation: Create detailed standard operating procedures with explicit material sources

• Cell-type and context consideration:

  • PKCδ regulation varies significantly between cell types

  • Different stimuli may activate distinct pathways affecting the same phosphorylation site

  • Example resolution: In HSV-1 research, viral strain specificity explains contradictory phosphorylation patterns

• Temporal dynamics analysis:

  • Conduct high-resolution time-course experiments

  • Apparent contradictions may reflect different sampling timepoints

  • Methodology: Synchronize cells before stimulation; sample at multiple timepoints

• Antibody specificity verification:

  • Cross-validate findings with multiple antibody clones

  • Confirm epitope specificity with peptide competition assays

  • Consider phosphorylation-state specific mass spectrometry as orthogonal verification

  • Critical control: Include samples where Ser645 is mutated to alanine

• Integrated multi-omics approach:

  • Combine transcriptomics, proteomics, and phosphoproteomics

  • Assess concordance between mRNA, protein abundance, and phosphorylation

  • Resolve discrepancies through systems biology modeling

• Accounting for phosphorylation stoichiometry:

  • Determine relative proportion of PKCδ phosphorylated at Ser645

  • Low stoichiometry may explain detection inconsistencies

  • Method: Quantitative mass spectrometry using phosphatase treatment controls

Case study from the literature: Contradictory findings regarding PKCδ's role in cell survival versus apoptosis were resolved by identifying context-dependent phosphorylation patterns that direct different downstream effector engagement .